https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-Announces-Updates-Designed-to-Strengthen-IW-3718-Phase-III-Program-for-Refractory-Gastroesophageal-Reflux-Disease-GERD/default.aspx
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-Announces-Updates-Designed-to-Strengthen-IW-3718-Phase-III-Program-for-Refractory-Gastroesophageal-Reflux-Disease-GERD/default.aspx